Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.0040 +0.0015 (+60.00%)
Streaming Delayed Price Updated: 11:54 AM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pressure Biosciences

< Previous 1 2 3 4 5 6 7 8 9 Next >
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray
Via Investor Brand Network
BioMedNewsBreaks — Pressure BioSciences Inc. (PBIO) to Host Business and Financial Update Teleconference
Via Investor Brand Network
BioMedNewsBreaks — Pressure BioSciences Inc. (PBIO) Schedules Business, Financial Update
Via Investor Brand Network
BioMedNewsBreaks — Pressure BioSciences Inc. (PBIO) Subsidiary Plans Expansion to Successful New Premium Collection
Via Investor Brand Network
Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Reports Initial Offering in Uncle Bud’s New Premium Collection Sees ‘Enthusiastic Customer Response’
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Significant Success with Recent Acquisition
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Consolidate All Operations in New Boston-Based Facility
Via Investor Brand Network
Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces New UB Product Line, Plans Investor Teleconference
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Upcoming Investor Teleconference to Discuss Key Company Milestones
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Closes on Acquisition of Uncle Bud’s in All-Stock Transaction
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures New Client Launching Around UltraShear(TM) Nanoemulsions Platform
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Tremendous Opportunity Through Strategic Merger, UltraShear
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Moves to Acquire Uncle Bud’s, Accelerate UltraShear(TM) Technology into Multiple Markets
Via Investor Brand Network
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
EQNX::TICKER_START (OTCQB:PBIO),(NASDAQ:CGC),(NASDAQ:TLRY),(NASDAQ:CRON),(OTCQX:CWBHF) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets
Strategic Merger Combines Uncle Bud’s Globally-Recognized Brand of 70 Products and 865K Member On-Line Community with PBIO’s Strong Scientific Capabilities, Technology Platforms, and Patent Estate Toni... 
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
From FN Media Group LLC
Via GlobeNewswire
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets
From Pressure BioSciences, Inc.
Via Business Wire
Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UltraShear(TM) Platform Featured in Food Technology Article
Via Investor Brand Network
Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Publication of Report Showing Potential for Proprietary UltraShear(TM) Platform
Via Investor Brand Network
Pressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Veterans Service Team Announce Launch of ‘Valor CBD’
Via Investor Brand Network
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2023 Financial Report, Business Update
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2023 Results, Provide Business Update
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Nano CB ‘Vastly Outperforms Current Technologies,’ According to Independent Study
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Peer-Reviewed Scientific Study Independently Confirms Pressure BioSciences’ UltraShear Nanoemulsion Platform Vastly Outperforms Current Technologies, Delivering CBD with Unprecedented Speed, Efficiency, Reliability, and Bioavailability
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.